Yunhua Chang
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The Heterogeneous Interplay Between Metabolism and Mitochondrial Activity in Colorectal Cancer.
Journal: Journal of personalized medicine
Published: October 15, 2025
Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Journal: EMBO molecular medicine
Published: September 16, 2024
Ferroptosis Inducers Upregulate PD-L1 in Recurrent Triple-Negative Breast Cancer.
Journal: Cancers
Published: November 26, 2023
Adverse Crosstalk between Extracellular Matrix Remodeling and Ferroptosis in Basal Breast Cancer.
Journal: Cells
Published: June 07, 2023
mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions.
Journal: Cell death & disease
Published: May 04, 2023
CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Journal: EMBO molecular medicine
Published: April 26, 2023
Sex and Circadian Timing Modulate Oxaliplatin Hematological and Hematopoietic Toxicities.
Journal: Pharmaceutics
Published: August 08, 2022
BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
Journal: International journal of molecular sciences
Published: April 13, 2021
BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways.
Journal: Aging
Published: October 02, 2019
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 04, 2017
Last Updated: 09/26/2026